-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OO0txWstHJ77P+T6CCcozcu5wp9X+e2gocv8+F7NoTtfP3InMdjxdOxK2AOIK46x 8tzBjUxRdd7A1fXaKpHlyg== 0000037076-97-000029.txt : 19970222 0000037076-97-000029.hdr.sgml : 19970222 ACCESSION NUMBER: 0000037076-97-000029 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970213 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PERSEPTIVE BIOSYSTEMS INC CENTRAL INDEX KEY: 0000859640 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 042987616 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43358 FILM NUMBER: 97529713 BUSINESS ADDRESS: STREET 1: 500 OLD CONNECTICUT PATH CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 5083837700 MAIL ADDRESS: STREET 1: 500 OLD CONNECTICUT PATH CITY: FRAMINGHAM STATE: MA ZIP: 01701 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: FIRSTAR INVESTMENT RESEARCH & MANAGEMENT CO /WI/ CENTRAL INDEX KEY: 0000894194 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 391357350 STATE OF INCORPORATION: WI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 777 E WISCONSIN AVENUE STREET 2: SUITE 1800 CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 4147656750 MAIL ADDRESS: STREET 1: 777 E WISCONSIN AVENUE STREET 2: SUITE 1800 CITY: MILWAUKEE STATE: WI ZIP: 53202 FORMER COMPANY: FORMER CONFORMED NAME: FIRSTAR INVESTMENT RESEARCH & MANAGEMENT CO /WI/ DATE OF NAME CHANGE: 19940207 SC 13G/A 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Name of Issuer: Perseptive Biosystems, Inc. Title of Class of Securities: Common Stock, Par $.01 CUSIP Number: 715271 102 *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 715271 102 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Firstar Investment Research & Management Company 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [x] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION State of organization: Wisconsin NUMBER OF 5. SOLE VOTING POWER SHARES 174,900 BENEFICIALLY 6. SHARED VOTING POWER OWNED BY 321,400 EACH 7. SOLE DISPOSITIVE POWER REPORTING 209,300 PERSON 8. SHARED DISPOSITIVE POWER WITH 321,400 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 530,700 shares 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 2.5% 12. TYPE OF REPORTING PERSON* IA Item 1(a). Name of Issuer: Perseptive Biosystems, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 500 Old Connecticut Path Framingham, Massachusetts 01701 Item 2(a). Name of Person Filing: Firstar Investment Research & Management Company Item 2(b). Address of Principal Business Office or, if none, Residence: 777 E. Wisconsin Avenue Milwaukee, Wisconsin 53202 Item 2(c). Citizenship: State of organization: Wisconsin Item 2(d). Title of Class of Securities: Common Stock, Par $.01 Item 2(e). CUSIP Number: 715271 102 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) [ ] Broker or Dealer registered under section 15 of the Act (b) [ ] Bank as defined in section 3(a)(6) of the Act (c) [ ] Insurance Company as defined in section 3(a)(19) of the Act (d) [ ] Investment Company registered under section 8 of the Investment Company Act (e) [x] Investment Adviser registered under section 203 of the Investment Advisers Act of 1940 (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income of 1974 or Endowment Fund; see 240.13d-1(b)(1)(ii)(F) (g) [ ]Parent Holding Company, in accordance with 240.13d-1(b)(ii)(G) (Note: See Item 7) (h) [ ] Group in accordance with 240.13d-1(b)(1)(ii)(H) Item 4. Ownership: (a) Amount Beneficially Owned as of December 31, 1996: 530,700 shares (b) Percent of Class: 2.5% (c) Number of Shares as to which such person has: (i) sole power to vote or to direct the vote: 174,900 (ii) shared power to vote or to direct to the vote: 321,400 (iii) sole power to dispose or to direct the disposition of: 209,300 (iv) shared power to dispose ore to direct the disposition of: 321,400 Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, shares beneficially owned by the filing person. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. Not Applicable Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 1997 FIRSTAR INVESTMENT RESEARCH & MANAGEMENT COMPANY By: /s/ Jeffrey Squires Name/Title: Jeffrey Squires, Operations Officer POWER OF ATTORNEY With Respect to Section 13 Reports Know all men by these present, that the undersigned hereby constitutes and appoints Jeffrey Squires, Operations Officer, its true and lawful attorney and agent at any time and from time to time to execute for and on behalf of the undersigned initial and amended reports on Schedules 13G in accordance with Section 13(d) of the Securities Exchange Act of 1934 (the "Act") and the rules promulgated thereunder, and to file the same with the Securities and Exchange Commission. The undersigned grants said attorney and agent full power and authority to do and perform each and every act and thing requisite, necessary and proper to be done in the exercise of any of the rights and powers therein granted, hereby ratifying and confirming all that each said attorney and agent shall lawfully do or cause to be done by virtue hereof and the rights and powers herein granted. The undersigned hereby acknowledges that the attorney and agent appointed herein does not assume any responsibilities of the undersigned under Section 13 of the Act. This Power of Attorney shall remain in full force and effect unless and until revoked by the undersigned by written notice delivered to said attorney and agent. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the 10th day of February, 1997. FIRSTAR INVESTMENT RESEARCH & MANAGEMENT COMPANY By: /s/ Mary Ellen Stanek Mary Ellen Stanek, President -----END PRIVACY-ENHANCED MESSAGE-----